Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk

Medicine (United States)

Volumn 95, Issue 27, 2016, Pages

  Ren, Honggang ^a   Zhang, Yue ^a   Yao, Yonghua ^b   Guo, Tao ^a   Wang, Huafang ^a   Mei, Heng ^a   Hu, Yu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shi Dong Hospital   (China)

Author keywords

IL 6; meta analysis; polymorphism; thrombosis disorders

Indexed keywords

INTERLEUKIN 6;

ARTERY DISEASE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED CLINICAL TRIAL (TOPIC); ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEREDITY; HUMAN; INDIA; INDIAN; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; SYSTEMATIC REVIEW; THROMBOSIS; ALLELE; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THROMBOSIS;

EID: 84978759496     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004030     Document Type: Article

References (61)

1. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451:914-8
2. Rosner SA, Ridker PM, Zee RYL, et al. Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician's Health Study. Hum Genet 2005;118:287-94
3. Harker LA. TheMerckManual of Diagnosis and Therpy. 17th ed. 1999; Whitehouse Station, NJ USA:Merck Research Laboratories. Merck Res Lab, 918-9
4. Chakraborty B, Chowdhury D, Vishnoi G, et al. Interleukin-6 gene-174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 2013;22:683-9
5. Xu B, Niu X-B, Wang Z-D, et al. IL-6-174GC polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep 2011;38:2589-96
6. Mao X, Ke Z, Liu S, et al. IL-1(+3953C/T,-511T/C and IL-6-174C/G polymorphisms in association with tuberculosis susceptibility: A metaanalysis. Gene 2015;573:75-83
7. Hua Y, Guo X, Huang Q, et al. Association between interleukin-6-174G/ C polymorphism and the risk of Alzheimer's disease: a meta-analysis. Int J Neurosci 2013;123:626-35
8. Hu S, Chen Y, Sun X-D, et al. Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: a meta-analysis. Genet Test Mol Biomark 2014;18:127-30
9. Gao J, Zhang A, Pan W, et al. Association between IL-6-174G/C polymorphism and the risk of sepsis and mortality: a systematic review and meta-analysis. PloS One 2015;10:e0118843
10. Zhou W, Zhang S, Hu Y, et al. Meta-analysis of the associations between TNF-A or IL-6 gene polymorphisms and susceptibility to lung cancer. Eur J Med Res 2015;20:28
11. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76
12. Bennermo M, Nordin M, Lundman P, et al. Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: a case-control study. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res 2011;31:259-64
13. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58
14. Chootrakool H, Shi JQ, Yue R. Meta-analysis and sensitivity analysis for multi-arm trials with selection bias. Stat Med 2011;30: 1183-98
15. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34
16. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34
17. Fang L, Zhou C, Bai S, et al. The C825T polymorphism of the G-protein (3 gene as a risk factor for depression: a meta-analysis. PloS One 2015;10:e0132274
18. Humphries SE, Luong LA, Ogg MS, et al. The interleukin-6-174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001;22: 2243-52
19. Georges JL, Loukaci V, Poirier O, et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med Berl Ger 2001;79:300-5
20. Nauck M, Winkelmann BR, Hoffmann MM, et al. The interleukin-6 G (-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med Berl Ger 2002;80:507-13
21. Bennet AM, Prince JA, Fei GZ, et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003;171:359-67
22. Licastro F, Chiappelli M, Caldarera CM, et al. The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 2004;125: 575-9
23. Lieb W, Pavlik R, Erdmann J, et al. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 2004;97:205-12
24. Kelberman D, Hawe E, Luong LA, et al. Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 2004;92:1122-8
25. Chiappelli M, Tampieri C, Tumini E, et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 2005;32:349-53
26. Sie MPS, Sayed-Tabatabaei FA, Oei H-H, et al. Interleukin 6-174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 2006;26:212-7
27. Coker A, Arman A, Soylu O, et al. Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int J Immunogenet 2011;38:201-8
28. Vakili H, Ghaderian SMH, Akbarzadeh Najar R, et al. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron Artery Dis 2011;22:299-305
29. Biswas S, Ghoshal PK, Mandal N. Synergistic effect of anti and proinflammatory cytokine genes and their promoter polymorphism with STelevation of myocardial infarction. Gene 2014;544:145-51
30. Revilla M, Obach V, Cervera A, et al. A-174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction. Neurosci Lett 2002;324:29-32
31. Pola R, Flex A, Gaetani E, et al. Synergistic effect of-174G/C polymorphism of the interleukin-6 gene promoter and 469E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke. Stroke J Cereb Circ 2003;34:881-5
32. Greisenegger S, Endler G, Haering D, et al. The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res 2003;110:181-6
33. Flex A, Gaetani E, Papaleo P, et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke J Cereb Circ 2004;35:2270-5
34. Karahan ZC, Deda G, Sipahi T, et al. TNF-alpha-308G/A and IL-6-174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb Res 2005;115:393-8
35. Chamorro A, Revilla M, Obach V, et al. The-174G/C polymorphism of the interleukin 6 gene is a hallmark of lacunar stroke and not other ischemic stroke phenotypes. Cerebrovasc Dis Basel Switz 2005;19:91-5
36. Balding J, Livingstone WJ, Pittock SJ, et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci 2004;173:200-3
37. Lalouschek W, Schillinger M, Hsieh K, et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med 2006;44:918-23
38. Banerjee I, Gupta V, Ahmed T, et al. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull 2008;75:158-65
39. Tong Y, Wang Z, Geng Y, et al. The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in twoChinesepopulations.BiochemBiophysResCommun2010;391:481-5
40. Yang X, Feng L, Li C, et al. Association of IL-6-174GC and-572CG polymorphisms with risk of young ischemic stroke patients. Gene 2014;539:258-62
41. Pieroni F, Lourenço DM, Morelli VM, et al. Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY). Thromb Res 2007;120:221-9
42. Vormittag R, Hsieh K, Kaider A, et al. Interleukin-6 and interleukin-6 promoter polymorphism (-174) G C in patients with spontaneous venous thromboembolism. Thromb Haemost 2006;95:802-6
43. Beckers MMJ, Ruven HJT, Haas FJLM, et al. Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism. Eur J Intern Med 2010;21:289-92
44. Matos MF, Lourenço DM, Orikaza CM, et al. The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6-174GC, IL-8-251AT and MCP-1-2518AG in the risk of venous thromboembolism: a casecontrol study. Thromb Res 2011;128:216-20
45. Pieroni F, Lourenço DM, Morelli VM, et al. Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY). Thromb Res 2007;120:221-9
46. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-26
47. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43
48. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001;88:10K-5K
49. Johnson CY, Tuite A, Morange PE, et al. The factor XII-4CT variant and risk of common thrombotic disorders: a HuGE review and metaanalysis of evidence from observational studies. Am J Epidemiol 2011;173:136-44
50. Sie MPS, Sayed-Tabatabaei FA, Oei H-H , et al. Interleukin 6-174g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 2006;26:212-7
51. Neumann FJ, Ott I, Marx N, et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 1997;17:3399-405
52. van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994;179:1253-9
53. Nikpay M, Goel A, Won H-H, et al. A comprehensive 1,000 Genomesbased genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015;47:1121-30
54. Deloukas P, Kanoni S, et al. CARDIoGRAMplusC4D, Consortium-Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 2013;45:25-33
55. NINDS, Stroke Genetics Network (SiGN), International Stroke Genetics Consortium (ISGC)Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol 2015
56. Germain M, Saut N, Greliche N, et al. Genetics of venous thrombosis: insights from a new genome wide association study. PloS One 2011;6: e25581
57. Kumar P, Yadav AK, Kumar A, et al. Association between interleukin-6 (G174C and G572C) promoter gene polymorphisms and risk of ischaemic stroke: a meta-analysis. Ann Neurosci 2015;22:61-9
58. Jin Y, Wang Q, Wang G, et al. Common polymorphisms in the interleukin-6 gene and myocardial infarction risk: a meta-analysis. Genet Test Mol Biomark 2014;18:330-40
59. Tuttolomondo A, Di Raimondo D, Forte GI, et al. Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 2012;58:398-405
60. Zintzaras E. Impact of Hardy-Weinberg equilibrium deviation on allelebased risk effect of genetic association studies and meta-analysis. Eur J Epidemiol 2010;25:553-60
61. Thakkinstian A, McElduff P, D'Este C, et al. A method for meta-analysis of molecular association studies. Stat Med 2005;24:1291-306